S71 Novel Diagnostic Approaches in Endocrine Hypertension

Program: Symposia
Clinical/Translational Session
Monday, April 4, 2016: 11:45 AM-1:15 PM
BR West (BCEC)
Irina Bancos, MD, Mayo Clinic, Rochester, MN

Nothing to Disclose: IB
11:45 AM
Graeme Eisenhofer, PhD, Medical Clinic III, University Hospital Carl Gustav Carus, Dresden, Germany
Nothing to Disclose: GE
12:15 PM
Elisabeth F.C. van Rossum, MD, PhD, Internal Medicine, Erasmus MC, Rotterdam, Netherlands
Nothing to Disclose: EFCV
12:45 PM
Andrew S Powlson, MA, MB, BChir, MRCP(UK), Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom
Nothing to Disclose: ASP
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire